ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogle, M. F.
Right arrow Articles by Levy, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogle, M. F.
Right arrow Articles by Levy, R. J.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2003;75:1267-1273
© 2003 The Society of Thoracic Surgeons

Original article: cardiovascular

Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep

Matthew F. Ogle, MSa, Sheila J. Kelly, BSa, Richard W. Bianco, BSb, Robert J. Levy, MDc*

a Heart Valve Division, St. Jude Medical Inc, St. Paul, Minnesota, USA
b Department of Experimental Surgery, University of Minnesota, Minneapolis, Minnesota, USA
c Division of Cardiology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Accepted for publication September 16, 2002.

* Address reprint requests to Dr Levy, Children’s Hospital of Philadelphia, Abramson Pediatric Research Center, Suite 702, 3516 Civic Center Blvd, Philadelphia, PA 19104, USA.
e-mail: levyr{at}email.chop.edu

BACKGROUND: Calcification of glutaraldehyde fixed bioprosthetic heart valve replacements frequently leads to the clinical failure of these devices. Previous research by our group has demonstrated that ethanol pretreatment prevents bioprosthetic cusp calcification, but not aortic wall calcification. We have also shown that aluminum chloride pretreatment prevents bioprosthetic aortic wall calcification. This study evaluated the combined use of aluminum and ethanol to prevent both bioprosthetic porcine aortic valve cusp and aortic wall calcification in rat subcutaneous implants, and the juvenile sheep mitral valve replacement model.

METHODS: Glutaraldehyde fixed cusps and aortic wall samples were pretreated sequentially first with aluminum chloride (AlCl3) followed by ethanol pretreatment. These samples were then implanted subdermally in rats with explants at 21 and 63 days. Stent mounted bioprostheses were prepared either sequentially as previously described or differentially with AlCl3 exposure restricted to the aortic wall followed by ethanol pretreatment. Mitral valve replacements were carried out in juvenile sheep with elective retrievals at 90 days.

RESULTS: Rat subdermal explants demonstrated that sequential exposure to AlCl3 and ethanol completely inhibited bioprosthetic cusp and aortic wall calcification compared with controls. However the sheep results were markedly different. The differential sheep explant group exhibited very low levels of cusp and wall calcium. The glutaraldehyde group exhibited little cusp calcification, but prominent aortic wall calcification. All sheep in the two groups previously described lived to term without evidence of valvular dysfunction. In contrast, animals in the sequential group exhibited increased levels of cusp calcification. None of the animals in this group survived to term. Pathologic analysis of the valves in the sequential group determined that valve failure was caused by calcification and stenosis of the aortic cusps.

CONCLUSIONS: The results clearly demonstrate that a combination of aluminum and ethanol reduced aortic wall calcification and prevented cuspal calcification. Furthermore, this study demonstrates that exclusion of aluminum from the cusp eliminated the cuspal calcification seen when aluminum and ethanol treatments were administered in a sequential manner.




This article has been cited by other articles:


Home page
 CirculationHome page
R. A. Manji, L. F. Zhu, N. K. Nijjar, D. C. Rayner, G. S. Korbutt, T. A. Churchill, R. V. Rajotte, A. Koshal, and D. B. Ross
Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection
Circulation, July 25, 2006; 114(4): 318 - 327.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. N. Clark, M. F. Ogle, P. Ashworth, R. W. Bianco, and R. J. Levy
Prevention of Calcification of Bioprosthetic Heart Valve Cusp and Aortic Wall With Ethanol and Aluminum Chloride
Ann. Thorac. Surg., March 1, 2005; 79(3): 897 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. J. Schoen and R. J. Levy
Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention
Ann. Thorac. Surg., March 1, 2005; 79(3): 1072 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. E. David and J. Ivanov
Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves?
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 939 - 941.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.